Combined PKC and MEK inhibition for treating metastatic uveal melanoma

MS Sagoo, JW Harbour, J Stebbing, AM Bowcock - Oncogene, 2014 - nature.com
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Combined PKC and MEK inhibition for treating metastatic uveal melanoma

MS Sagoo, JW Harbour, J Stebbing… - …, 2014 - utsouthwestern.elsevierpure.com
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Combined PKC and MEK inhibition for treating metastatic uveal melanoma

M Sagoo, J Harbour, J Stebbing, A Bowcock - Oncogene, 2014 - scholarship.miami.edu
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Combined PKC and MEK inhibition for treating metastatic uveal melanoma

MS Sagoo, JW Harbour, J Stebbing… - …, 2014 - pubmed.ncbi.nlm.nih.gov
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Combined PKC and MEK inhibition for treating metastatic uveal melanoma.

MS Sagoo, JW Harbour, J Stebbing, AM Bowcock - Oncogene, 2014 - europepmc.org
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

[PDF][PDF] Combined PKC and MEK inhibition for treating metastatic uveal melanoma

MS Sagoo, JW Harbour, J Stebbing, AM Bowcock - Oncogene, 2014 - academia.edu
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Combined PKC and MEK inhibition for treating metastatic uveal melanoma.

MS Sagoo, JW Harbour, J Stebbing… - Oncogene, 2014 - search.ebscohost.com
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

[HTML][HTML] Combined PKC and MEK inhibition for treating metastatic uveal melanoma

MS Sagoo, JW Harbour, J Stebbing, AM Bowcock - Oncogene, 2014 - ncbi.nlm.nih.gov
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Combined PKC and MEK inhibition for treating metastatic uveal melanoma

MS Sagoo, JW Harbour, J Stebbing, AM Bowcock - Oncogene, 2014 - go.gale.com
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …

Combined PKC and MEK inhibition for treating metastatic uveal melanoma.

MS Sagoo, JW Harbour, J Stebbing, AM Bowcock - Oncogene, 2014 - europepmc.org
Uveal melanoma (UM) is the most common primary intraocular malignancy and the second
most common form of melanoma. UM has a strong tendency for metastatic disease, and no …